Are Analysts Bearish Phibro Animal Health Corporation (NASDAQ:PAHC) After Last Week?

April 26, 2018 - By Ellis Scott

Investors sentiment decreased to 1.41 in Q4 2017. Its down 0.07, from 1.48 in 2017Q3. It dropped, as 17 investors sold Phibro Animal Health Corporation shares while 42 reduced holdings. 25 funds opened positions while 58 raised stakes. 19.14 million shares or 1.25% less from 19.38 million shares in 2017Q3 were reported.
Seizert Ltd Liability stated it has 0.06% in Phibro Animal Health Corporation (NASDAQ:PAHC). Jpmorgan Chase & Com holds 0% or 55,024 shares in its portfolio. Comerica Financial Bank stated it has 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC). Manufacturers Life Insur Company The invested in 0% or 15,914 shares. Ubs Asset Americas has 0% invested in Phibro Animal Health Corporation (NASDAQ:PAHC) for 58 shares. First Tru Advsr Lp holds 0% or 17,571 shares in its portfolio. Morgan Stanley holds 0% or 210,496 shares in its portfolio. Schwab Charles Invest holds 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC) for 146,967 shares. Amer Gp holds 0% in Phibro Animal Health Corporation (NASDAQ:PAHC) or 15,689 shares. Swiss Bancorp invested in 31,900 shares or 0% of the stock. State Of Wisconsin Board has invested 0% in Phibro Animal Health Corporation (NASDAQ:PAHC). Macquarie Gp Inc Ltd holds 5,491 shares or 0% of its portfolio. National Bank & Trust Of America Corporation De holds 0% or 86,550 shares. Moreover, South Dakota Investment Council has 0.03% invested in Phibro Animal Health Corporation (NASDAQ:PAHC) for 35,400 shares. First Manhattan has invested 0% in Phibro Animal Health Corporation (NASDAQ:PAHC).

Since February 9, 2018, it had 0 insider buys, and 13 selling transactions for $12.62 million activity. BENDHEIM JACK also sold $961,200 worth of Phibro Animal Health Corporation (NASDAQ:PAHC) shares. The insider BFI Co. – LLC sold 24,000 shares worth $961,200. The insider Bendheim Daniel M sold 3,960 shares worth $158,647. 10,000 shares were sold by Warras Dean J, worth $356,200 on Friday, February 9.

Phibro Animal Health Corporation (NASDAQ:PAHC) Ratings Coverage

Among 3 analysts covering Phibro Animal Health (NASDAQ:PAHC), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Phibro Animal Health had 3 analyst reports since February 6, 2018 according to SRatingsIntel. Morgan Stanley maintained it with “Underweight” rating and $36 target in Wednesday, February 7 report. Piper Jaffray maintained it with “Buy” rating and $45.0 target in Wednesday, February 7 report. The stock has “Neutral” rating by Credit Suisse on Tuesday, February 6. Below is a list of Phibro Animal Health Corporation (NASDAQ:PAHC) latest ratings and price target changes.

07/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $45.0 Maintain
07/02/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $30 New Target: $36 Maintain
06/02/2018 Broker: Credit Suisse Old Rating: Neutral New Rating: Neutral Old Target: $37 New Target: $39 Maintain

The stock increased 1.74% or $0.75 during the last trading session, reaching $43.75. About 37,290 shares traded. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 41.44% since April 26, 2017 and is uptrending. It has outperformed by 29.89% the S&P500.

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.76 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 28.45 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Phibro Animal Health Corporation (NASDAQ:PAHC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.